No Detail Found!

Overview on Pathophysiology, Diagnosis, and Management of Biotinidase Deficiency in Pediatrics

Author(s)
Alaa Saud Alyasi Maternity and Children Hospital, Tabuk, Saudi Arabia
Faisal Mohammed Alharbi Maternity and Children Hospital, Tabuk, Saudi Arabia
Ahmad Sughaier Albalawi Maternity and Children Hospital, Tabuk, Saudi Arabia
Fawaz Khalifah Alanazi Maternity and Children Hospital, Tabuk, Saudi Arabia
Turki Saleh Alshehri Maternity and Children Hospital, Tabuk, Saudi Arabia
Badriah Abdulrahman Alsabah Maternity and Children Hospital, Tabuk, Saudi Arabia
Abstract
A condition that interferes with the biotin cycle is known as biotinidase (BTD) deficiency. Endogenous biotin recycling is hampered, and different carboxylase deficits result depending on the amount of enzyme activity. There are two types of BTD insufficiency, which are determined by the amount of BTD Enzyme present in the serum. Pathogenic BTD gene mutations have been reported globally in a wide range of different ways. BTD deficiency is caused by complete and partial BTD gene mutations. The severe pathogenic disease is caused by profound BTD deficiency. Neuro-cutaneous symptoms are frequently evident in infants with significant deficiencies. Around the world, a significant percentage of neonates suffer from a partial deficiency. Although they are mostly asymptomatic, symptoms can sometimes arise under stressful circumstances. The treatment for symptomatic children or babies with positive screening results is lifelong oral biotin supplementation. The former may experience either a partial or full relief of symptoms. Results of neonatal screening programs confirm that postnatal biotin therapy shields patients with Biotinidase deficiency from symptoms. The article provides an overview of biotinidase deficiency in children, addresses programs for newborn screening for early detection and treatment of BTD-deficient infants, and explains how early treatment and proper patient care are facilitated by accurate diagnosis.
Publication Details
Page(s) 99-105
Published Journal: Archives of Pharmacy Practice, Volume: 14, Issue: 2, Year: 2023

Request the full text from PASTIC

Keywords
Seizures, Biotin, Biotinidase, Multiple carboxylase deficiency
0

Citations

0

Downloads

49

Views